BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1605141)

  • 21. Yield of the screening review of systems: a study on a general medical service.
    Mitchell TL; Tornelli JL; Fisher TD; Blackwell TA; Moorman JR
    J Gen Intern Med; 1992; 7(4):393-7. PubMed ID: 1506944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utilization of fecal occult blood testing in the institutionalized elderly.
    Klos SE; Drinka P; Goodwin JS
    J Am Geriatr Soc; 1991 Dec; 39(12):1169-73. PubMed ID: 1960360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uses and misuses of oxygen in hospitalized patients.
    Small D; Duha A; Wieskopf B; Dajczman E; Laporta D; Kreisman H; Wolkove N; Frank H
    Am J Med; 1992 Jun; 92(6):591-5. PubMed ID: 1605139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice style differences between family physicians and internists.
    Conry CM; Pace WD; Main DS
    J Am Board Fam Pract; 1991; 4(6):399-406. PubMed ID: 1767691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of stool guaiac conversion following extracorporeal shock wave lithotripsy.
    Bauer JJ; Finger MJ; Heidenberg HB; Preston DM; Moses FM; Watson RA; Irby PB
    Urology; 1997 Aug; 50(2):192-4. PubMed ID: 9255287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of fecal occult blood tests for early detection of gastrointestinal pathology.
    Stelling HP; Maimon HN; Smith RA; Haddy RI; Markert RJ
    Arch Intern Med; 1990 May; 150(5):1001-5. PubMed ID: 2331181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The guaiac test and colorectal pathology. Clinical evaluation].
    Angelici A; Piermattei A; Palumbo P; Turano R; Vietri F
    Minerva Chir; 1993 Mar; 48(6):273-6. PubMed ID: 8506047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Screening for colo-rectal neoplasms by the study of fecal occult blood].
    Castiglione G; Pacini F; Maltoni G
    Quad Sclavo Diagn; 1984 Dec; 20(4):440-50. PubMed ID: 6537553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal occult blood tests in occult gastrointestinal bleeding.
    Bond JH
    Semin Gastrointest Dis; 1999 Apr; 10(2):48-52. PubMed ID: 10361895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience.
    Zappa M; Castiglione G; Paci E; Grazzini G; Rubeca T; Turco P; Crocetti E; Ciatto S
    Int J Cancer; 2001 Apr; 92(1):151-4. PubMed ID: 11279619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H; Tao S
    Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity.
    Blom J; Törnberg S
    J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower specificity of occult-blood test on stool collected by digital rectal examination.
    Zhang B; Nakama H; Fattah AS; Kamijo N
    Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colon-cancer screening in dialysis patients.
    Ajam M; Ramanujam LS; Gandhi VC; Leehey DJ; Ing TS; Schnell TG; Daugirdas JT
    Artif Organs; 1990 Apr; 14(2):95-7. PubMed ID: 2350261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for colorectal cancer using the Hemoccult II stool guaiac slide test.
    Cummings KM; Michalek A; Mettlin C; Mittelman A
    Cancer; 1984 May; 53(10):2201-5. PubMed ID: 6704908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
    Hundt S; Haug U; Brenner H
    Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of simple screening criteria on utilization of low-yield bacterial stool cultures in a Children's Hospital.
    Zaidi AK; Macone A; Goldmann AD
    Pediatrics; 1999 Jun; 103(6 Pt 1):1189-92. PubMed ID: 10353927
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.